Sign in Subscribe

Lauren Okafor for Doctronic

Signs of depression in men: Why it often goes unrecognized

Signs of depression in men: Why it often goes unrecognized

Signs of depression in men: Why it often goes unrecognized Depression does not look the same for everyone. For millions of men, the signs go unrecognized because they show up in unexpected ways. Instead of crying or expressing sadness, men might become angry, withdrawn, or reckless. These behaviors get labeled

Autism in adults: Late diagnosis and what it means

Autism in adults: Late diagnosis and what it means

Autism in adults: Late diagnosis and what it means Adult autism diagnosis is becoming increasingly common as awareness grows and diagnostic criteria evolve. Understanding what this means can be life-changing for many individuals who have spent years feeling different without knowing why. The journey to late autism diagnosis often

Is Foundayo safe long term? What the clinical trial data actually shows

Is Foundayo safe long term? What the clinical trial data actually shows

Is Foundayo safe long term? What the clinical trial data actually shows Foundayo (orforglipron) represents the first oral GLP-1 receptor agonist approved for type 2 diabetes, offering patients an alternative to daily injections. However, understanding its long-term safety requires careful examination of available clinical trial data and ongoing

GLP-1 side effects: What 400,000 patient reports reveal

GLP-1 side effects: What 400,000 patient reports reveal

GLP-1 side effects: What 400,000 patient reports reveal GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have become some of the most prescribed medications in the country. Millions of people take them for Type 2 diabetes and weight management, and for good reason — the